Expertise in
14
conditions

Urs M. Fischer

Bern, BE, CH 
Clinical Trials:Currently Recruiting for 2 Trials
Expertise in
14
conditions
Bern, BE, CH 
OverviewLocationsClinical Research

Overview

Urs Fischer practices in Bern, Switzerland. Fischer is highly rated in 14 conditions, according to our data. Their top areas of expertise are Stroke, Migraine with Brainstem Aura, Familial Hemiplegic Migraine, Thrombectomy, and Craniectomy.

Their clinical research consists of co-authoring 420 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Bern, BE, Switzerland
Other Locations
Basel, BS, Switzerland
Cantonal Hospital St. Gallen, St. Gallen All In Switzerland, Sankt Gallen, SG, Switzerland
Lugano, TI, Switzerland
St Gallen Cantonal Hospital, St Gallen
Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT), Substudies: MRI, Cognitive
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT), Substudies: MRI, Cognitive
Enrollment Status: Recruiting
Publish Date: April 22, 2024
Intervention Type: Drug
Study Drugs: Telmisartan, Amlodipine, Indapamide
Study Phase: Phase 3
MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention: The MOSES-study. An International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention: The MOSES-study. An International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
Enrollment Status: Recruiting
Publish Date: August 16, 2023
Intervention Type: Drug
Study Drugs: Dabigatran, Apixaban, Edoxaban, Aspirin, Clopidogrel
Study Phase: Phase 3
EnDovascular Therapy Plus Best Medical Treatment (BMT) Versus BMT Alone for MedIum VeSsel Occlusion sTroke - a prAgmatic, International, Multicentre, Randomized triaL (DISTAL)
EnDovascular Therapy Plus Best Medical Treatment (BMT) Versus BMT Alone for MedIum VeSsel Occlusion sTroke - a prAgmatic, International, Multicentre, Randomized triaL (DISTAL)
Enrollment Status: Active_not_recruiting
Publish Date: December 24, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
Swiss Trial of Decompressive Craniectomy Versus Best Medical Treatment of Spontaneous Supratentorial Intracerebral Hemorrhage (SWITCH): a Randomized Controlled Trial
Swiss Trial of Decompressive Craniectomy Versus Best Medical Treatment of Spontaneous Supratentorial Intracerebral Hemorrhage (SWITCH): a Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: November 14, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
Solitaire™ With the Intention For Thrombectomy Plus Intravenous t-PA Versus DIRECT Solitaire™ Stent-retriever Thrombectomy in Acute Anterior Circulation Stroke
Solitaire™ With the Intention For Thrombectomy Plus Intravenous t-PA Versus DIRECT Solitaire™ Stent-retriever Thrombectomy in Acute Anterior Circulation Stroke
Enrollment Status: Completed
Publish Date: November 14, 2024
Intervention Type: Drug, Device
Study Phase: Not Applicable
Early Minimally Invasive Image Guided Endoscopic Evacuation of Intracerebral Haemorrhage: a Prospective Pilot Study
Early Minimally Invasive Image Guided Endoscopic Evacuation of Intracerebral Haemorrhage: a Prospective Pilot Study
Enrollment Status: Completed
Publish Date: August 15, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
Endovascular Therapy vs Medical Management of PosterIor Cerebral Artery Occlusion Stroke
Endovascular Therapy vs Medical Management of PosterIor Cerebral Artery Occlusion Stroke
Enrollment Status: Completed
Publish Date: June 04, 2024
Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
Enrollment Status: Completed
Publish Date: July 18, 2023
Intervention Type: Drug
Study Phase: Not Applicable
View 6 Less Clinical Trials

420 Total Publications

Case 341.
Case 341.
Journal: Radiology
Published: May 27, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Fischer's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 37 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile